Clinical Trial Update: Dietary Supplement (Beta-Glucans) in Allergic Patients Undergoing Subcutaneous Immunotherapy. [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating beta-glucans as an adjunct to subcutaneous immunotherapy in allergic rhinitis and asthma patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Allergic Rhinoconjunctivitis
• Asthma
• Rhinitis

Drugs mentioned

• Beta-glucans (beta-glucan)

Snippet

Sponsor: Gala Servicios Clinicos S.L. | Conditions: Rhinitis, Allergic Rhinoconjunctivitis | Phase 4 | Status: COMPLETED